Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Bipolar I Depression
NCT00094432Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jun 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jun 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00094432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094432.